This protocol applies to adults aged 18 years or older presenting with gonococcal conjunctivitis who have a documented cephalosporin allergy. The allergy status is the defining clinical factor — it excludes standard cephalosporin-containing regimens and requires a specific alternative approach.
Patient aged ≥18 with confirmed or suspected gonococcal conjunctivitis and a known cephalosporin allergy, making the usual first-choice antibiotic class unavailable.
Management in this setting relies on an oral antibiotic alternative to cephalosporins. The specific agent, its dose, and any supporting guidance are defined in the full structured protocol.